Loading the security overview…
Where the tokens are
| Quarter | Reported | EPS | EPS vs year ago | Revenue | Revenue vs year ago | Consensus EPS |
|---|---|---|---|---|---|---|
| Q2 FY26ended Jun 27, 2026 | Jul 23, 2026 | $4.68 | +9.3% | $11.99B | +10.5% | $5.72 |
| Q1 FY26ended Mar 28, 2026 | Apr 29, 2026 | $4.43 | +11.3% | $11.01B | +6.2% | $5.25 |
| Q4 FY25ended Dec 31, 2025 | — | $5.21 | +8.5% | $12.22B | +7.2% | — |
| Q3 FY25ended Sep 27, 2025 | — | $4.27 | +0.5% | $11.12B | +4.9% | — |
| Q2 FY25ended Jun 28, 2025 | — | $4.28 | +5.9% | $10.86B | +3.0% | — |
| Q1 FY25ended Mar 29, 2025 | — | $3.98 | +15.0% | $10.36B | +0.2% | — |
| Q4 FY24ended Dec 31, 2024 | — | $4.80 | +14.3% | $11.40B | +4.7% | — |
| Q3 FY24ended Sep 28, 2024 | — | $4.25 | −3.8% | $10.60B | +0.2% |
Growth compares each quarter with the same fiscal quarter a year earlier, and is left blank where that quarter is missing or its figure was zero or a loss. Consensus is the estimate published before each report. It usually refers to adjusted EPS, so it is shown beside the GAAP figure rather than subtracted from it: the difference would not be a beat or a miss.
Figures describe Thermo Fisher shares, not any token. As of Jul 23, 2026, from Massive's standardised financials and the earnings calendar.
| — |
| Q2 FY24ended Jun 29, 2024 | — | $4.04 | — | $10.54B | — | — |
| Q1 FY24ended Mar 30, 2024 | — | $3.46 | — | $10.35B | — | — |
| Q4 FY23ended Dec 31, 2023 | — | $4.20 | — | $10.89B | — | — |
| Q3 FY23ended Sep 30, 2023 | — | $4.42 | — | $10.57B | — | — |